Topic resource collection
Approved comparison material connected to this topic.
774 resourcesRead both sides
Researchers selecting peptides for chronic inflammation studies must match peptide mechanism to experimental model and research question. The following table compares five peptides with distinct mechanisms and inflammatory target…
Before we look at the potential of joint healing peptides, we need to understand the conventional options. The treatment types vary from simple ones you can do at home, to surgery. The appropriate way to care for aches and inflam…
Feature Aβ (1-40) Aβ (1-42) Length 40 amino acids 42 amino acids Aggregation propensity Lower Higher Hydrophobicity Moderate Greater C-terminal hydrophobic character Oligomer formation Generally less aggregation-prone Commonly us…
Two distinct peptide categories serve different functions in combat sports protocols. Growth hormone secretagogues (GHRP-2, GHRP-6, Ipamorelin, MK-677) stimulate the pituitary gland to release endogenous GH in pulsatile waves. Mi…
BPC-157 Upregulates VEGF, FGF-2, EGF at injury sites. Drives angiogenesis and collagen deposition 250–500 mcg/day, injected near injury site Acute tendon injuries, pulley strains, medial epicondylitis 10–21 days First-line peptid…
BPC-157 Angiogenesis, VEGF upregulation, collagen synthesis Tendinopathy, gut permeability, musculoskeletal injury 250–500mcg SC twice daily 60 days at 2–8°C Most versatile tissue repair peptide. Works systemically and locally Th…
MOTS-C Activates AMPK → mitochondrial biogenesis and substrate utilisation 5–10mg twice weekly subcutaneous 4–6 weeks (mitochondrial density) Best choice for athletes prioritising oxidative capacity over short-term recovery TB-50…
BPC-157 Upregulates VEGF and PDGF receptors for angiogenesis and collagen deposition Tendon repair, ligament reconstruction, orthopaedic surgery 250–500 mcg 1–2× daily Subcutaneous near wound site Days 1–21 post-surgery Strongest…
BPC-157 VEGF upregulation, angiogenesis induction Soft tissue repair (tendons, ligaments, muscle strains) 250–500 mcg daily, subcutaneous injection near injury site Subcutaneous Most reproducible evidence for accelerated tendon h…
CJC-1295/Ipamorelin Stimulates pulsatile GH secretion; improves lipolysis and lean mass retention 200–300mcg each, 3–5×/week subcutaneous Body composition changes visible at 8–12 weeks; metabolic markers improve at 4–6 weeks Mode…
Before selecting peptides for performance or recovery applications, understanding the evidence base, dosing precision, and receptor saturation dynamics is essential. Not all peptides marketed to athletes have clinical data suppor…
BPC-157 VEGF upregulation, angiogenesis promotion 250–500mcg daily subcutaneous 7–14 days for tissue repair effects Tendon/ligament injuries, joint pain, gut inflammation Gold standard for injury recovery in research settings. Me…
Before selecting a peptide for PCOS research, match the mechanism to your model's primary phenotype. Insulin resistance, inflammation, or combined metabolic-reproductive dysregulation. Each peptide addresses different pathways, a…
GLP-1 Agonists (Semaglutide, Tirzepatide) Delays gastric emptying, reduces ghrelin rebound, improves insulin sensitivity 0.25mg-2.4mg weekly (titrated over 16-20 weeks) Appetite suppression in 3-7 days; measurable fat loss by wee…
BPC-157 VEGF upregulation, collagen synthesis Tendon repair, chronic injury recovery 250–500 mcg SubQ 1–2x daily Animal models + anecdotal (no human RCTs) Strong mechanistic basis; most reliable for localized soft tissue healing …
BPC-157 VEGF upregulation, angiogenesis Tendon/ligament repair, gut healing 200–500 mcg/day split doses Subcutaneous injection Gold standard for injury recovery. Most validated peptide for soft tissue repair MK-677 Ghrelin recept…
Before selecting peptides, understand the distinct role each category plays in supporting strength development. Growth Hormone Secretagogues (GHRP-2, GHRP-6, Ipamorelin, MK-677) Stimulate pituitary GH release via ghrelin receptor…
MOTS-C Mitochondrial-derived peptide, activates AMPK, regulates nuclear gene expression for metabolic flexibility Mitochondrial dysfunction, insulin resistance, declining exercise capacity 5–10mg, 2–3×/week Subcutaneous or intran…
Before selecting a peptide protocol, compare mechanisms, administration logistics, and clinical endpoints relevant to postmenopausal physiology. BPC-157 VEGF upregulation, collagen synthesis Daily subcutaneous (250–500mcg) 18% in…
CJC-1295 (with DAC) GHRH receptor agonist. Sustained GH pulse elevation Once weekly Restores anabolic signaling, supports lean mass retention, improves sleep quality 2–8°C after reconstitution, use within 28 days Best single pept…